Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Land

Showing results (101-110 of 142) with videos related to

Pageof 15
Sort By:
Tobacco Control|March 28, 2023
Changing patterns of cigarette and ENDS transitions in the USA: a multistate transition analysis of youth and adults in the PATH Study in 2015-2017 vs 2017-2019Andrew F Brouwer, Jihyoun Jeon, Evelyn Jimenez-Mendoza, et al.
The Annals of Thoracic Surgery|May 24, 2008
Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasmArjun Pennathur, James D Luketich, Rodney J Landreneau, et al.
Cancer Epidemiology|April 27, 2013
Genetic variation in ESR2 and estrogen receptor-beta expression in lung tumorsJi Young Song, Jill M Siegfried, Brenda Diergaarde, et al.
Medrxiv : the Preprint Server for Health Sciences|December 25, 2025
Transitions in cigarette and ENDS use in the PATH Study: a multistate transition model analysis of adults in 2021-2022 compared to previous yearsAndrew F Brouwer, Olivia K Roberts, Jihyoun Jeon, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2008
Immunization with analog peptide in combination with CpG and montanide expands tumor antigen-specific CD8+ T cells in melanoma patientsJulien Fourcade, Pavol Kudela, Pedro A Andrade Filho, et al.
Medrxiv : the Preprint Server for Health Sciences|May 1, 2026
Transitions in ENDS and cigarette use among youth in the PATH Study from 2015-2023: a multistate transition modeling analysisOlivia K Roberts, Jihyoun Jeon, Evelyn Jimenez-Mendoza, et al.
Journal of Cancer Survivorship : Research and Practice|August 27, 2016
Quality of life and symptoms in long-term survivors of colorectal cancer: results from NSABP protocol LTS-01Hiroko Kunitake, Marcia M Russell, Ping Zheng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patientsJulien Fourcade, Pavol Kudela, Zhaojun Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemiaKenneth A Foon, Michael Boyiadzis, Stephanie R Land, et al.
Molecular Cancer Therapeutics|July 23, 2008
Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesisLaura P Stabile, Mary E Rothstein, Phouthone Keohavong, et al.
Pageof 15

Showing results (101-110 of 142) with videos related to

Sort By:
Pageof 15
Tobacco Control|March 28, 2023
Changing patterns of cigarette and ENDS transitions in the USA: a multistate transition analysis of youth and adults in the PATH Study in 2015-2017 vs 2017-2019Andrew F Brouwer, Jihyoun Jeon, Evelyn Jimenez-Mendoza, et al.
The Annals of Thoracic Surgery|May 24, 2008
Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasmArjun Pennathur, James D Luketich, Rodney J Landreneau, et al.
Cancer Epidemiology|April 27, 2013
Genetic variation in ESR2 and estrogen receptor-beta expression in lung tumorsJi Young Song, Jill M Siegfried, Brenda Diergaarde, et al.
Medrxiv : the Preprint Server for Health Sciences|December 25, 2025
Transitions in cigarette and ENDS use in the PATH Study: a multistate transition model analysis of adults in 2021-2022 compared to previous yearsAndrew F Brouwer, Olivia K Roberts, Jihyoun Jeon, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2008
Immunization with analog peptide in combination with CpG and montanide expands tumor antigen-specific CD8+ T cells in melanoma patientsJulien Fourcade, Pavol Kudela, Pedro A Andrade Filho, et al.
Medrxiv : the Preprint Server for Health Sciences|May 1, 2026
Transitions in ENDS and cigarette use among youth in the PATH Study from 2015-2023: a multistate transition modeling analysisOlivia K Roberts, Jihyoun Jeon, Evelyn Jimenez-Mendoza, et al.
Journal of Cancer Survivorship : Research and Practice|August 27, 2016
Quality of life and symptoms in long-term survivors of colorectal cancer: results from NSABP protocol LTS-01Hiroko Kunitake, Marcia M Russell, Ping Zheng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patientsJulien Fourcade, Pavol Kudela, Zhaojun Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemiaKenneth A Foon, Michael Boyiadzis, Stephanie R Land, et al.
Molecular Cancer Therapeutics|July 23, 2008
Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesisLaura P Stabile, Mary E Rothstein, Phouthone Keohavong, et al.
Pageof 15